-The Hindu     Protesters see attempt by EU to undermine Indian judiciary in the EU-FTA pact People living with HIV, cancer patient groups and public health activists came out on the streets on Wednesday demanding that India reject the European Union's demands in the European Union-India Free Trade Agreement (EU-India FTA) negotiations. The protests coincide with Prime Minister Manmohan Singh's visit to Germany to meet Chancellor Angela Merkel with the FTA on top of...

-The Hindu     The shortened lifespan of the quarry workers of Uttar Pradesh is spent breaking stones and residing among the pollution- laden boulders Mired with sandy roads and rocky terrain, the landscape in south-western Allahabad creates a remarkable mirage under the blue sky. Some of the larger rocks here have sizeable craters formed in them -- a sign of their depletion over time, by an activity that is hazardous yet critical to the...

-The Hindu Raipur: For the first time since the formation of Chhattisgarh in 2000, the National Human Rights Commission (NHRC) will hold a "full commission" sitting in State capital Raipur. NHRC chairperson Justice K. G. Balakrishnan and its members, Justice B. C. Patel and retired diplomat Satyabrat Pal, will hold several sessions till Friday. According to sources in the NHRC, investigating officers and the special rapporteur of the commission had visited the State,...

-The Times of India Big pharma may be crying hoarse over India's "weak'' intellectual property environment, but over the past five years or so, they have introduced only a handful of their patented blockbusters in the country. That's not all. The contribution of patented drugs in the Rs 72,000-crore pharma retail market is not even 1%, indicating that multinationals have been traditionally slow and have a poor track record in introducing...

-The Hindu     Drug patents are designed to create profits that enable more research on diseases affecting millions. But in practice, they have often generated super profits for big pharma companies while erecting access barriers for the poor. The Novartis case spotlights much that is wrong with the system. The rejection of the Novartis petition challenging one of the most progressive tenets of the Indian Patents Act (1970), as amended in 2005 by...